<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <title>Diana Toivola</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <style>
    body {
      font-family: sans-serif;
      background-color: #f0f2f5;
      margin: 0;
      padding: 20px;
      display: flex;
      justify-content: center;
    }
    .card {
      background: #fafafa;
      max-width: 1000px;
      width: 100%;
      border-radius: 12px;
      padding: 30px;
      box-shadow: 0 8px 20px rgba(0, 0, 0, 0.12);
      border: 2px solid #ccc;
      margin-top: 20px;
      box-sizing: border-box;
    }
    .profile-header {
      display: flex;
      flex-wrap: wrap;
      align-items: flex-start;
      justify-content: space-between;
      margin-bottom: 30px;
    }
    .profile-left {
      display: flex;
      flex-wrap: wrap;
      align-items: center;
      gap: 20px;
      flex: 1;
    }
    .profile-photo {
      width: 140px;
      max-width: 100%;
      height: auto;
      border-radius: 10px;
      border: 2px solid #ccc;
      background-color: #f9f9f9;
      flex-shrink: 0;
    }
    .profile-info {
      flex: 1;
      min-width: 200px;
    }
    .profile-info h1 {
      margin: 0;
      font-size: 26px;
    }
    .profile-info p {
      margin: 4px 0;
      font-size: 16px;
      color: #333;
    }
    .profile-info a {
      color: #0077cc;
      text-decoration: none;
      font-size: 16px;
    }
    .profile-info a:hover {
      text-decoration: underline;
    }
    .logo {
      width: 100px;
      height: auto;
      margin-top: 10px;
    }
    h2 {
      margin-top: 30px;
      font-size: 20px;
    }
    ul {
      padding-left: 20px;
    }
    li {
      margin-bottom: 8px;
    }
    .back-button {
      display: inline-block;
      margin-top: 40px;
      font-size: 14px;
      color: #333;
      text-decoration: none;
    }
    .back-button:hover {
      text-decoration: underline;
    }

    @media (max-width: 600px) {
      .profile-header {
        flex-direction: column;
        align-items: center;
        text-align: center;
      }
      .profile-left {
        flex-direction: column;
        align-items: center;
      }
      .profile-info h1 {
        font-size: 22px;
      }
      .logo {
        display: none;
      }
    }
  </style>
</head>
<body>
  <div class="card">
    <div class="profile-header">
      <div class="profile-left">
        <img src="/supervisor-portfolio/images/AboAkademiUniversity.png" alt="Profile Photo" class="profile-photo">
        <div class="profile-info">
          <h1>Diana Toivola</h1>
          <p><strong>Group Name:</strong> Epithelial Biology Lab</p>
          <p><strong>Subject:</strong> Cell Biology</p>
          <p><strong>University:</strong> Åbo Akademi University</p>
          
            <p><strong>Lab Website:</strong> <a href="https://toivola-lab.org/" target="_blank">link</a></p>
          
          
            <p><strong>AboCRIS Profile:</strong> <a href="https://research.abo.fi/sv/persons/diana-toivola" target="_blank">link</a></p>
          
        </div>
      </div>
      <img src="https://www.abo.fi/wp-content/uploads/2019/09/AboAkademiUniversity.png" alt="ÅAU Logo" class="logo">
    </div>

    
    <h2>Areas of Expertise</h2>
    <ul><li>Epithelial cell biology of gastrointestinal organs and related glands including the endocrine pancreas</li><li>Cytoskeletal intermediate filaments protein regulation and function and molecular roles in health and disease, especially simple epithelial keratins and nuclear lamins</li><li>Auto-immune diseases, Inflammatory bowel diseases, type I diabetes, and colorectal cancer</li><li>Mouse disease modelling</li><li>Non-invasive diagnostics development of intestinal diseases</li></ul>
    

    
    <h2>Research Projects</h2>
    <ul><li>Dysregulation of keratins in intestinal inflammation with biomarker potential</li><li>Noninvasive in vitro assays to detect and monitor inflammatory bowel diseases</li><li>A colon-specific mouse model for colorectal cancer</li><li>Keratins as tumor suppressors and guardians of intestinal health</li><li>Beta-cell cytoskeletal keratin 18 and its putative type 1 diabetes-associated variant in beta-cell function</li></ul>
    

    
    <h2>Special Methodologies & Techniques</h2>
    <ul><li>Mouse disease modelling, especially models of colitis, colorectal cancer and diabetes</li><li>Intestinal crypt isolation and organoid culture (mini-gut)</li><li>Isolation of islets of Langerhans and 3D culture</li><li>Beta-cell and colon cancer cell lines</li><li>Microscopy, digital histopathology and fluorescence-based imaging methods</li><li>Cell, molecular, biochemical methods</li><li>Immunoassay and non-invasive imaging methods development</li></ul>
    

    
    <h2>Major Funding & International Networks</h2>
    <ul><li>Current funding: InFLAMES flagship, Business Finland, Novo Nordisk Fonden, Medicinska understödsföreningen Liv och Hälsa, Diabetes Research Foundation Finland</li><li>Networks: Intermediate filament community, American Society for Cell Biology, Gut Research Community in Finland, Gastroenterology organizations in Finland, and USA</li></ul>
    

    
    <h2>Selected Publications</h2>
    <ul>
      
        
        <li>
          
            Defining a timeline of colon pathologies after keratin 8 loss: rapid crypt elongation and diarrhea are followed by epithelial erosion and cell exfoliation. Am. J. Physiol., Gastro. Liver Physiol. 2024.  DOI: <a href="https://doi.org/10.1152/ajpgi.00140.2023" target="_blank">10.1152/ajpgi.00140.2023</a>
          
        </li>
      
        
        <li>
          
            β-cell keratin 8 maintains islet mechanical integrity, mitochondrial ultrastructure and β-cell glucose transporter 2 plasma membrane targeting. 2024. Am. J. Physiol.-Cell Physiol.  DOI: <a href="https://doi.org/10.1152/ajpcell.00123.2024" target="_blank">10.1152/ajpcell.00123.2024</a>
          
        </li>
      
        
        <li>
          
            Colonocyte keratins stabilize mitochondria and contribute to mitochondrial energy metabolism. 2024. Am. J. Physiol.- Gastrointestinal Liver Physiol.  DOI: <a href="https://doi.org/10.1152/ajpgi.00220.2023" target="_blank">10.1152/ajpgi.00220.2023</a>
          
        </li>
      
        
        <li>
          
            Colonocyte keratin 7 expression is expressed  de novo in inflammatory bowel diseases and associated with pathological changes and drug-resistance. Sci. Rep. 2022.  DOI: <a href="https://doi.org/10.1038/s41598-022-26603-2" target="_blank">10.1038/s41598-022-26603-2</a>
          
        </li>
      
        
        <li>
          
            Targeted deletion of keratin 8 in intestinal epithelial cells disrupts tissue integrity and predisposes to tumorigenesis in the colon. Cell. Mol. Life. Sci. 2022.  DOI: <a href="https://doi.org/10.1007/s00018-021-04081-5" target="_blank">10.1007/s00018-021-04081-5</a>
          
        </li>
      
    </ul>
    

    

    <p style="text-align: center;">
      <a href="../index.html" class="back-button">← Back to Portfolio</a>
    </p>
  </div>
</body>
</html>